|Bid||72.07 x 1000|
|Ask||73.45 x 800|
|Day's Range||72.82 - 74.06|
|52 Week Range||50.77 - 92.18|
|Beta (3Y Monthly)||1.36|
|PE Ratio (TTM)||56.53|
|Earnings Date||Nov 4, 2019 - Nov 8, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||70.71|
REDWOOD CITY, Calif., Aug. 21, 2019 /PRNewswire/ -- Genomic Health today announced that, based on results from the prospective TAILORx1 and PlanB2 studies, the 16th St. Gallen International Breast Cancer Conference Expert Panel has recommended the Oncotype DX Breast Recurrence Score® test to guide chemotherapy treatment use for patients with hormone-receptor positive, HER-2 negative early-stage breast cancer with and without lymph node involvement (up to three positive nodes). In particular, the panelists recognized the value of the landmark TAILORx study results and noted that women with node-negative cancers and Recurrence Score® results ≤25 do not need chemotherapy.3 This group represents up to about 80% of patients who may be safely spared chemotherapy.
Seeking to win where no one has succeeded before in cancer and build out its own manufacturing, this Mountain View company takes its place in a growing line of Bay Area biotech IPOs.
NEW YORK, NY / ACCESSWIRE / August 16, 2019 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New ...
WILMINGTON, Del., Aug. 15, 2019 -- Rigrodsky & Long, P.A. announces that it is investigating: Condor Hospitality Trust, Inc. (NYSE: CDOR) regarding possible breaches of.
NEW YORK, Aug. 14, 2019 -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: United Financial Bancorp, Inc..
Amgen (AMGN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
President and CEO of Genomic Health Inc (30-Year Financial, Insider Trades) Kimberly J Popovits (insider trades) sold 50,000 shares of GHDX on 08/09/2019 at an average price of $73.76 a share. Continue reading...
Under the terms of the transaction, each share of Genomic common stock will be converted into the right to receive $27.50 in cash and $44.50 in shares of Exact Sciences for each share of Genomic common stock owned. Under the terms of the agreement, each share of Navigant common stock will be converted into the right to receive $28.00 in cash for each share of Navigant common stock owned.
Shareholder rights attorneys at Robbins Arroyo LLP are investigating the proposed acquisition of Genomic Health, Inc. (GHDX) by Exact Sciences Corp. (EXAS). On July 29, 2019, the two companies announced the signing of a definitive merger agreement pursuant to which Exact Sciences will acquire Genomic Health. Under the terms of the agreement, Genomic Health shareholders will receive $27.50 in cash and $44.50 in shares of Exact Sciences stock for each share of Genomic Health stock that they own, representing total consideration of $72.00 per Genomic Health share.
BALA CYNWYD, PA / ACCESSWIRE / August 2, 2019 / Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Genomic Health, Inc. (“Genomic” ...
NEW ORLEANS , Aug. 2, 2019 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale ...
The merger of Genomic Health (GHDX) with Exact Sciences will combine two of the strongest brands in cancer diagnostics, Cologuard and OncotypeDX, providing platform for growth.
WILMINGTON, Del., Aug. 01, 2019 -- Rigrodsky & Long, P.A. announces that it is investigating: MidSouth Bancorp, Inc. (NYSE: MSL) regarding possible violations of law.
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 1) Grifols SA - ADR ADR Class B (NASDAQ: GRFS ) Odonate ...
NEW YORK, NY / ACCESSWIRE / August 1, 2019 / Halper Sadeh LLP, a global investor rights law firm, reminds investors that it is investigating the following companies: LegacyTexas Financial Group, Inc. (NASDAQ: ...
WILMINGTON, Del., July 31, 2019 -- Rigrodsky & Long, P.A. announces that it is investigating: Genomic Health, Inc. (NASDAQ GS: GHDX) regarding possible breaches of.
NEW YORK, July 31, 2019 -- Halper Sadeh LLP, a global investor rights law firm, reminds investors that it is investigating the following companies: Total System Services, Inc..
Kim Popovits helped build Genomic Health into a leading molecular diagnostics company over a 17-year career. She could leave the Redwood City company with millions of dollars.